Technologies that can change the delivery characteristics of drugs have been around for decades, but there has been a recent acceleration in the pace of their adaptation to psychiatric medications. Most notable is the increasing availability of numerous agents in oral sustained-release formulations that increase a drug’s duration of action. By allowing the frequency of dosing to be reduced from 2 or 3 times a day to once a day, compliance can be greatly enhanced.
Save
Cite
Advertisement
GAM ID: sidebar-top